Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This is a pilot study designed to evaluate the effectiveness of continuous glucose monitoring (CGM) within hours of delivery to predict long-term risk of Type 2 Diabetes Mellitus in patients diagnosed with gestational diabetes. Participants will be provided a CGM within 2 hours after delivery and wear the device for 24 hours. Participants will be instructed to peel off the device after 24 hours. Participants will also be asked to complete two surveys regarding their experience at 1-3 months postpartum and 12-14 months postpartum.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:
• Prenatal care at UCLA Health
• Planning to deliver at UCLA Ronald Reagan or UCLA Santa Monica
• Confirmed gestational diabetes diagnosis based on 2-step approach
• Maternal age \>= 18 years
Locations
United States
California
University of California, Los Angeles
RECRUITING
Los Angeles
Contact Information
Primary
Rujuta Sathe
RSathe@mednet.ucla.edu
310-794-8893
Backup
Dana Levin-Lopez, MPH
dlevinlopez@mednet.ucla.edu
310-794-8893
Time Frame
Start Date: 2025-09-28
Estimated Completion Date: 2030-06
Participants
Target number of participants: 50
Treatments
Other: Continuous Glucose Monitor
Administration of a Continuous Glucose Monitor within 2 hours after delivery for 24-hour collection of glycemic data.
Related Therapeutic Areas
Sponsors
Leads: University of California, Los Angeles